Ascelia Pharma - Complete Response Letter for Orviglance NDA
Additional clinical data and product documentation requestedUrgent FDA meeting to discuss next stepsVery low visibility: Valuation suspended until mor...
- Alligo
- Arctic Paper
- Ascelia Pharma
- BTS Group
- Byggmästaren
- Careium
- Catella
- Cavotec
- Clavister
- Coeli Private Equity
- Coor
- CTT Systems
- Donkey Republic
- Eastnine
- Eltel
- Embellence Group
- ES Group AB
- Ework Group
- Fastpartner
- Ferronordic
- Formpipe
- G5 Entertainment
- Generic
- Gentoo Media
- Impact Coatings
- Infrea
- Inission
- Isofol Medical
- I-tech
- Lumi Gruppen
- Medicover
- Midsona
- Nexam Chemical
- Nilörn
- Nolato
- NYAB
- Ogunsen
- OssDsign
- Ovzon
- Petrolia Noco
- Prevas
- Proact
- Qben Infra
- Qliro
- SinterCast
- Skolon
- Stenhus Fastigheter
- StrongPoint
- Studsvik
- Svedbergs Group
- Tempest Security
- Viscaria
- Xplora Technologies
Press the button and be introduced to a new random company!
Social media
Follow us on Twitter
Latest Equity Research
Fastpartner - Positive development on IFPM guidance NTM
Solid letting activity, but timing/impact uncertainLower interest rate assumptions and SBBs drive estimates2026e P/CEPS of 11x vs coverage average of ...
Fastpartner - Q2 on the soft side but positive guidance
NOI -2% y-o-y, 0.6% vs ABGSCe, -0.4% vs cons.Value changes of -0.64% vs ABGSCe of 0.28%Share to trade in-line with the sector on the back of this repo...
Prevas - Waiting for volumes to follow
Signs of stabilisation but pricing remains pressuredWe leave our estimates broadly unchangedTrading ~25% below Nordic peersA stabilising market, but p...
Midsona - Top-line recovery around the corner
Q2e: 1% organic growth and 4% EBITA marginLimited estimate changesTrading at NTM EV/EBITA of 10xQ2e: back to growthWe anticipate organic growth of 1% ...
Nolato - Nearing organic growth acceleration
Q2e: some GLP-1 ramp-up, more to come in H2eEstimates up on FX and higher growth in EngineeredTrading at 13x '26e EV/EBITA vs. historical average of 1...
Eltel - New services improving the financial profile
Q2e: big y-o-y earnings improvementRaised EBITA driven by increasing emerging service salesShare trading at 10x '26e EV/EBITA, goes to 7x in '28eQ2e: ...
Show more